Abstract

We report a case of an 80-year-old woman with severe mitral regurgitation, low ejection fraction, frailty, and acute decompensated heart failure. Due to her high surgical risk, transcatheter edge-to-edge repair using the MitraClip system (Abbott, Abbott Park, IL, USA) was attempted by the cardiology team. However, the procedure resulted in a posterior mitral leaflet tear with worsened severe mitral regurgitation. She was subsequently referred to our department, and owing to her clinical deterioration, urgent minimally invasive cardiac surgery mitral valve replacement was performed using a 29-mm bioprosthetic mitral valve (Epic; Abbott, Abbott Park, IL, USA). The patient had an uneventful recovery and was discharged on postoperative Day 13. Mitral valve surgery following failed MitraClip is considered high-risk, with elevated perioperative mortality. However, in frail patients with leaflet injury after MitraClip failure, minimally invasive cardiac surgery mitral valve replacement may represent a more appropriate and less invasive therapeutic option.

MitraClipminimally invasive cardiac surgery mitral valve replacementfrail patient

Introduction

In elderly patients, mitral regurgitation (MR) is often associated with frailty, left ventricular dysfunction, and multiple comorbidities, making surgical intervention high risk. Consequently, transcatheter edge-to-edge repair (TEER) using the MitraClip system has become a widely accepted therapeutic option in this population [1]. However, several complications could occur with TEER. Adverse events such as single leaflet device attachment (SLDA), leaflet perforation, or leaflet tear can result in persistent or recurrent MR [2, 3], sometimes necessitating surgical bailout.

Here, we report a case of urgent minimally invasive cardiac surgery mitral valve replacement (MICS-MVR) for posterior leaflet tear following failed MitraClip implantation in a frail elderly patient with acute decompensated heart failure.

Case report

An 80-year-old woman with a history of chronic kidney disease, ulcerative colitis, and dyslipidemia had been followed for severe MR for the past 6 years. She presented with progressive dyspnea and was admitted with acute decompensated heart failure. Transthoracic echocardiography (TTE) demonstrated significant prolapse of the A3 segment and a markedly reduced left ventricular ejection fraction (LVEF) of 30%. Given her frailty, impaired ventricular function, and multiple comorbidities, conventional surgical mitral valve repair was deemed high risk. Therefore, the MitraClip system was selected and performed by the cardiology team. During the MitraClip procedure, however, a posterior mitral leaflet tear occurred, resulting in worsened severe MR (Fig. 1). Consequently, the patient was referred to our department for operation.

Transesophageal echocardiography following the MitraClip procedure. (a) The posterior mitral leaflet is torn, resulting in a loss of continuity. (b) Mitral regurgitation is observed originating from the site of the tear.
Figure 1

Transesophageal echocardiography following the MitraClip procedure. (a) The posterior mitral leaflet is torn, resulting in a loss of continuity. (b) Mitral regurgitation is observed originating from the site of the tear.

Considering the persistent MR and the patient’s preserved general condition despite her frailty, MICS-MVR was performed via a right fourth intercostal space mini-thoracotomy. Cardiopulmonary bypass was established with femoral artery and vein cannulation. Intraoperative findings revealed a severe laceration extending from the A3 to P3 segments, with prolapse of A3 and two tears near the annulus on P3. A bioprosthetic mitral valve (Epic 29 mm; Abbott, Abbott Park, IL, USA) was implanted under direct vision (Fig. 2).

Intraoperative findings during minimally invasive mitral valve replacement. (a) Prolapse of the A3 segment and two tears in the P3 segment were observed. (b) Valve replacement was performed using a 29-mm Epic bioprosthesis.
Figure 2

Intraoperative findings during minimally invasive mitral valve replacement. (a) Prolapse of the A3 segment and two tears in the P3 segment were observed. (b) Valve replacement was performed using a 29-mm Epic bioprosthesis.

The patient was extubated on postoperative day (POD) 1 and discharged home on POD 13. Postoperative TTE showed no residual MR, a LVEF of 43%, and reduced left atrial volume (Fig. 3). At 1-year follow-up, the patient remained asymptomatic with stable valve function and no recurrence of MR.

One week postoperative transthoracic echocardiography. (a) The left atrium was reduced in size. (b) Mitral regurgitation was well controlled.
Figure 3

One week postoperative transthoracic echocardiography. (a) The left atrium was reduced in size. (b) Mitral regurgitation was well controlled.

Discussion

The MitraClip system has become an established treatment option for patients with severe MR who are considered high-risk or unsuitable for conventional surgery [1]. Although the procedure is generally safe, device-related complications such as SLDA, leaflet perforation, and leaflet tear have been reported in ~2%–6% of cases and are associated with increased morbidity and mortality [2, 3]. Among these, posterior leaflet injury is particularly concerning, as it often results in persistent MR and necessitates surgical bailout. Surgical intervention following TEER failure is technically challenging due to altered valve anatomy, advanced age, and patient frailty. Previous reports have indicated that surgical intervention after failed MitraClip implantation is associated with a substantial risk of major complications or perioperative mortality [4–6]. These findings highlight the importance of timely surgical referral and the consideration of less invasive approaches when feasible. In the present case, urgent MICS-MVR was successfully performed in a frail, elderly patient with reduced left ventricular function and multiple comorbidities. By avoiding sternotomy and limiting surgical trauma, the procedure enabled rapid MVR with an uneventful postoperative course. In cases of leaflet injury after MitraClip failure, MICS-MVR may offer an effective and practical therapeutic option, particularly for high-risk patients.

Acknowledgements

We would like to express our sincere gratitude to the dedicated healthcare professionals, as well as the patient whose medical records and data made this research possible.

Conflict of interest statement

None declared.

Funding

None declared.

References

1.

Feldman  

T
, Kar  
S
, Rinaldi  
M
, et al.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.
J Am Coll Cardiol
 2009;54:686–94.

2.

Maisano  

F
, Franzen  
O
, Baldus  
S
, et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.
J Am Coll Cardiol
 2013;62:1052–61.

3.

Citro  

R
, Prota  
C
, Silverio  
A
, et al.  Partial clip detachment and posterior mitral leaflet perforation after MitraClip implantation.
Int J Cardiol
 2014;172:e378–80.

4.

Bent  

DP
 Jr, Boova  
RS
. Minimally invasive mitral valve replacement after transcatheter edge-to-edge repair.
J Surg Case Rep
 2021;2021:rjab432.

5.

Inaba  

Y
, Kubo  
T
, Inoue  
T
, et al.  Surgical revision of failed MitraClip procedure for atrial functional mitral regurgitation.
J Artif Organs
 2022;25:174–7.

6.

Saito  

S
, Yamazaki  
K
, Kondo  
T
, et al.  Mitral valve replacement after failed MitraClip therapy: report of two cases.
J Artif Organs
 2015;18:177–80.

© The Author(s) 2025. Published by Oxford University Press and JSCR Publishing Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.